![William Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Li
Director/Board Member at
CEAPRO INC.
Net worth: 99 731 $ as of 30/07/2026
Profile
William W.
Li is the founder of The Angiogenesis Foundation, established in 1994, serving as President & Medical Director.
Current jobs include Independent Director at Ceapro, Inc. since 2014, Independent Director at Cypherpunk Technologies, Inc. since 2017, and Scientific Advisor at The Courtagen Group LLC.
Former jobs include Director at IBOD Imaging, Inc. from 2003 to 2006, Director at DOBI Medical Systems, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp.
from 2017 to 2019, Independent Director at COSCIENS Biopharma, Inc., and Director at Æterna Zentaris, Inc. Education includes undergraduate studies at Harvard College and a doctorate from the University of Pittsburgh School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2026 | 168,750 ( 0.16% ) | 99 731 $ | 30/07/2026 |
William Li active positions
| Companies | Position | Start |
|---|---|---|
| CEAPRO INC. | Director/Board Member | 19/11/2014 |
| CYPHERPUNK TECHNOLOGIES INC. | Director/Board Member | 31/12/2016 |
The Courtagen Group LLC
 The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
The Angiogenesis Foundation
 The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Founder | 31/12/1993 |
Former positions of William Li
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Director/Board Member | 23/09/2019 |
IBOD Imaging, Inc.
 IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Director/Board Member | 25/06/2006 |
Æterna Zentaris, Inc.
 Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Director/Board Member | - |
DOBI Medical Systems, Inc.
 DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Director/Board Member | - |
Training of William Li
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
IBOD Imaging, Inc.
IBOD Imaging, Inc. Medical SpecialtiesHealth Technology Develops devices for diagnosing breast cancer | Health Technology |
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
 Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
DOBI Medical Systems, Inc.
DOBI Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures an optical breast imaging system to aid in the detection of breast cancer | Health Technology |
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Angiogenesis Foundation
The Angiogenesis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in disrupting disease through angiogenesis | Commercial Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- William Li
